Archon Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Archon Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,645,443	Closed	-$16.4M	–	46
2022 Q4	$16.4M	Sell	1,645,443 -196,641	-11%	-$1.47M	4.76%	5
2022 Q3	$10.2M	Buy	1,842,084 +887,388	+93%	+$4.92M	1.8%	14
2022 Q2	$3.48M	Hold	954,696	–	–	0.8%	25
2022 Q1	$5.78M	Hold	954,696	–	–	0.71%	23
2021 Q4	$8.05M	Buy	954,696 +198,542	+26%	+$1.73M	1.06%	22
2021 Q3	$6.85M	Hold	756,154	–	–	0.97%	25
2021 Q2	$6.13M	Buy	+756,154	New	+$5.19M	0.69%	25

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Archon Capital Management's APEN Position: Q1 2023 in Review

Archon Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 1,645,443 shares — an estimated $16.4M sold.

Archon Capital Management first reported a position in APEN in Q2 2021 and held it in 7 quarters. The position peaked at $16.4M in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

Archon Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
Archon Capital Management sold 1,645,443 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $16.4M.
Archon Capital Management first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 7 quarters.
Archon Capital Management's Apollo Endosurgery, Inc. position peaked at $16.4M in Q4 2022.
89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Archon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.